Related Experiment Video
Updated: Jul 16, 2026

Isolation and Functional Analysis of Mitochondria from Cultured Cells and Mouse Tissue
Published on: March 23, 2015
Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells
Caroline Paris1, Jacques Bertoglio, Jacqueline Bréard
1INSERM U749, Faculté de Pharmacie Paris-Sud. 5, rue Jean-Baptiste Clément 92290, Châtenay-Malabry, France.
Abstract:
Hexadecylphosphocholine (HePC) is an anticancer agent whose effect has been shown to involve apoptosis induction but the signaling pathways leading to apoptosis remain to be elucidated. We show here that HePC induces activation of caspase-9, -3, and -8 via the intrinsic pathway, release of cytochrome c, activation and relocation of Bax to the mitochondria as well as the cleavage of Bid. Moreover, a lysosomal pathway characterized by partial lysosomal rupture, cathepsin B activation and relocation from lysosomes to the cytosol, is involved in HePC-induced apoptosis. A cathepsin B/L inhibitor partially suppresses caspase activation and apoptosis induction, indicating signaling between lysosomes and mitochondria. Conversely, the pancaspase inhibitor Q-VD-OPH inhibits lysosomal rupture, but only at early time points, suggesting that immediate lysosomal rupture involves caspases. Overexpression of Bcl-2, an anti-apoptotic protein known to prevent mitochondrial dysfunction, totally abrogates lysosomal destabilization and cell death.
Insights
Hexadecylphosphocholine (HePC) triggers cancer cell death through both intrinsic mitochondrial and lysosomal pathways. Signaling crosstalk between these pathways and caspase activation are crucial for HePC-induced apoptosis.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Hexadecylphosphocholine (HePC) is an anticancer agent.
- Its mechanism of action involves apoptosis induction, but signaling pathways are not fully understood.
Purpose of the Study:
- To elucidate the signaling pathways involved in Hexadecylphosphocholine (HePC)-induced apoptosis.
- To investigate the interplay between mitochondrial and lysosomal pathways in HePC-mediated cell death.
Main Methods:
- Assessing caspase activation (caspase-9, -3, -8).
- Monitoring cytochrome c release and Bax/Bid protein changes.
- Evaluating lysosomal integrity, cathepsin B activity, and relocation.
- Utilizing specific inhibitors (cathepsin B/L inhibitor, pancaspase inhibitor Q-VD-OPH) and Bcl-2 overexpression.
Main Results:
- HePC activates caspases-9, -3, and -8 via the intrinsic pathway, involving cytochrome c release, Bax relocation, and Bid cleavage.
- A lysosomal pathway with cathepsin B activation and cytosolic relocation contributes to HePC-induced apoptosis.
- Evidence of signaling crosstalk between lysosomes and mitochondria.
- Early lysosomal rupture is caspase-dependent, while Bcl-2 overexpression prevents lysosomal destabilization and cell death.
Conclusions:
- HePC induces apoptosis through a complex interplay of intrinsic mitochondrial and lysosomal pathways.
- Caspase activation and lysosomal integrity are critical components of HePC's anticancer effects.
- Targeting these pathways could enhance HePC efficacy.
Related Concept Videos
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
